Technical Analysis for IMDZ - Immune Design Corp.
|Grade||Last Price||% Change||Price Change|
IMDZ closed up 1.19 percent on Wednesday, November 22, 2017, on 63 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
|See historical IMDZ trend table...|
|Date||Alert Name||Type||% Chg|
|Nov 22||Narrow Range Bar||Range Contraction||0.00%|
|Nov 22||Doji - Bullish?||Reversal||0.00%|
|Nov 21||Narrow Range Bar||Range Contraction||1.19%|
|Nov 21||Stochastic Reached Oversold||Other||1.19%|
|Nov 20||Narrow Range Bar||Range Contraction||1.80%|
|Nov 20||Death Cross||Bearish||1.80%|
|Nov 17||NR7||Range Contraction||-3.41%|
|Nov 17||Narrow Range Bar||Range Contraction||-3.41%|
|Nov 16||Narrow Range Bar||Range Contraction||-3.41%|
|Nov 14||NR7||Range Contraction||-1.73%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Immune Design Corp., a clinical-stage immunotherapy company, focuses on the development of novel immune-based therapies based on its DCVex and GLAAS discovery platforms for cancer and other chronic conditions. Its product candidates in Phase I clinical trials comprise LV305, CMB305, and G305 for the treatment of solid tumor types, such as breast cancer, melanoma, non-small cell lung cancer, ovarian cancer, or sarcoma; and G100 for the treatment of patients with merkel cell carcinoma. The company was formerly known as VaccSys Inc. and changed its name to Immune Design Corp. in June, 2008. The company was founded in 2008 and is headquartered in Seattle, Washington.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more IMDZ news...
|52 Week High||13.05|
|52 Week Low||3.78|
|200-Day Moving Average||7.6166|
|50-Day Moving Average||7.3824|
|20-Day Moving Average||4.4085|
|10-Day Moving Average||4.39|
|Average True Range||0.4683|
|Chandelier Exit (Long, 3 ATRs )||3.8951|
|Chandelier Exit (Short, 3 ATRs )||5.1849|
|Upper Bollinger Band||4.9223|
|Lower Bollinger Band||3.8947|
|Percent B (%b)||0.35|
|MACD Signal Line||-0.9811|
|Market Cap||108.88 Million|
|Num Shares||25.6 Million|
|Price-to-Earnings (P/E) Ratio||-1.69|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||4.55|
|Resistance 3 (R3)||4.55||4.45||4.50|
|Resistance 2 (R2)||4.45||4.37||4.45||4.48|
|Resistance 1 (R1)||4.35||4.33||4.35||4.35||4.47|
|Support 1 (S1)||4.15||4.17||4.15||4.15||4.03|
|Support 2 (S2)||4.05||4.13||4.05||4.02|
|Support 3 (S3)||3.95||4.05||4.00|
|Support 4 (S4)||3.95|